Institut Curie: Neoplasms trials

The registry lists 15 Neoplasms studies with Institut Curie as lead sponsor. 6 are open to participants now and 0 have results posted.

Phase 2 2Phase 3 1No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast CancerRecruitingNCT07193394Phase 2
• Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in Paediatric OncologyRecruitingNCT05781295Not applicable
• Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs)RecruitingNCT05558644Not applicable
• ProActIF-01 Trial: Feasibility Study of an Individualized Program of Nutrition and Adapted Physical Activity in Frail Patients With Advanced Digestive CancersRecruitingNCT05441163Not applicable
• Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTARecruitingNCT05354765Not applicable
• Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4RecruitingNCT05088395Not applicable
• A Study to Evaluate the Efficacy and Toxicities of PLX038, in Patients With Locally Advanced or Metastatic Triple-negative Breast CancerTerminatedNCT06162351Phase 2
• The Integrated Support and Palliative in Cancer Day-care Hospital for Patients With Advanced Cancers: Impact on Quality of Life, Care Pathways and Support for Caregivers (HDJ-SPI)CompletedNCT04604873Not applicable
• Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)CompletedNCT04118062Not applicable
• Impact of Sick Peer Relation on Adaptation to Disease and on Treatment of Cancer-suffering Adolescents & Young AdultsCompletedNCT03964116Not applicable
• SHIVA02 - Evaluation of the Efficacy of Targeted Therapy Based on Tumor Molecular Profiling in Patients With Advanced Cancer Using Each Patient as Its Own Control (SHIVA02)CompletedNCT03084757Not applicable
• Impact of a Booklet-Question List on Cancer Patients or Their Families Seeking Prognostic Information During a Palliative Care ConsultationCompletedNCT02854293
• Use of Specific Genetic Alteration s of Tumoral Cells Identified by the Next Generation Sequencing Techniques (NGS) to Follow Peripheral Samples of Children With Metastatic and/or High Risk Solid Tumor - NGSKidsCompletedNCT02546453Not applicable
• MIRs03: Paravertebral Block With Ropivacaine Before Breast Cancer SurgeryCompletedNCT02408393Phase 3
• Test Semiquantitative Prostate Specific Antigen (PSA)CompletedNCT00853710Not applicable